Discovery may lead to development of safer immunosuppressants
Thursday, March 19, 2009 - 11:42
in Health & Medicine
Immunosuppressive treatment is necessary to prevent rejection of an organ after transplant and has great potential for treating chronic inflammatory diseases. However, currently available immunosuppressant drugs can pose serious health risks, restricting their long-term use. Now, new research findings may lead to the development of immunosuppressant drugs that have fewer adverse side effects. The study, published by Cell Press in the 13th March issue of the journal Molecular Cell, reveals detailed information about how drugs commonly used to prevent transplant rejection interact with their target...
Read the whole article on Science Centric
More from Science Centric
Related
- Discovery may lead to development of safer immunosuppressantsThu, 12 Mar 2009, 14:15:51 EDT
- Embryonic stem cells might help reduce transplantation rejectionMon, 15 Sep 2008, 13:29:28 EDT
- Kidney transplant patients may benefit from going off of certain immunosuppressive drugsWed, 18 Jun 2008, 12:42:24 EDT
- New technique eliminates toxic drugs in islet transplant in diabetic miceThu, 20 Nov 2008, 12:23:29 EST
- Major breakthrough in transplantation immunityTue, 7 Apr 2009, 9:21:58 EDT